Team | Year | Age | GS | G | IP | W | L | SV | BS | K | BB | H | HR | K% | BB% | HR% | LOB% | GB% | WHIP | BABIP | ERA | FIP | FIP- | xFIP | E-F | WAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mississauga - WCL (AA)
MSS - WCL (AA)
|
2057 | 23 | 0 | 11 | 27.1 | 0 | 1 | 0 | 0 | 8 | 8 | 26 | 4 | 7.2% | 7.21% | 3.6% | 68.0% | 52.9% | 1.24 | .244 | 4.94 | 5.72 | 137 | 5.46 | -0.78 | -0.38 |
Dearborn Heights - CPL (A)
DEA - CPL (A)
|
2057 | 23 | 0 | 19 | 35.1 | 0 | 1 | 0 | 0 | 31 | 16 | 32 | 3 | 20.3% | 10.46% | 2.0% | 80.8% | 60.6% | 1.36 | .287 | 3.31 | 4.56 | 104 | 4.52 | -1.25 | 0.01 |
Nassau - DRAKE
NAS - DRAKE
|
2056 | 22 | 15 | 15 | 93.1 | 3 | 7 | 0 | 0 | 62 | 29 | 110 | 8 | 15.0% | 7.04% | 1.9% | 66.3% | 54.2% | 1.49 | .340 | 5.30 | 4.80 | 101 | 4.98 | 0.50 | 1.24 |
Dearborn Heights - CPL (A)
DEA - CPL (A)
|
2055 | 21 | 6 | 30 | 57.1 | 2 | 6 | 4 | 3 | 46 | 29 | 53 | 5 | 18.5% | 11.69% | 2.0% | 67.1% | 58.1% | 1.43 | .304 | 4.40 | 4.98 | 106 | 5.03 | -0.58 | 0.15 |
Nassau - DRAKE
NAS - DRAKE
|
2054 | 20 | 1 | 27 | 63.0 | 2 | 2 | 1 | 0 | 61 | 26 | 69 | 11 | 21.3% | 9.06% | 3.8% | 74.2% | 58.2% | 1.51 | .314 | 4.86 | 5.17 | 124 | 4.14 | -0.31 | -0.68 |
Nassau - DRAKE
NAS - DRAKE
|
2053 | 19 | 18 | 25 | 91.1 | 0 | 14 | 0 | 1 | 59 | 58 | 131 | 25 | 12.6% | 12.39% | 5.3% | 60.0% | 58.3% | 2.07 | .341 | 9.16 | 7.90 | 198 | 5.74 | 1.26 | -2.76 |
Oshawa - SNL (R)
OSH - SNL (R)
|
2052 | 18 | 4 | 9 | 28.1 | 0 | 2 | 0 | 0 | 18 | 18 | 25 | 4 | 14.0% | 13.95% | 3.1% | 55.8% | 48.4% | 1.52 | .247 | 5.40 | 6.09 | 141 | 6.10 | -0.69 | -0.24 |
Nassau - DRAKE
NAS - DRAKE
|
2051 | 17 | 9 | 9 | 34.1 | 0 | 5 | 0 | 0 | 36 | 16 | 50 | 6 | 20.7% | 9.20% | 3.4% | 56.8% | 56.9% | 1.92 | .393 | 8.13 | 5.07 | 121 | 4.62 | 3.06 | 0.05 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2051 | 17 | 7 | 7 | 29.2 | 1 | 1 | 0 | 0 | 28 | 15 | 24 | 2 | 22.8% | 12.20% | 1.6% | 85.6% | 67.3% | 1.31 | .290 | 2.12 | 3.72 | 75 | 4.73 | -1.60 | 0.94 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2050 | 16 | 8 | 8 | 29.1 | 0 | 1 | 0 | 0 | 44 | 31 | 20 | 2 | 30.3% | 21.38% | 1.4% | 59.8% | 62.8% | 1.74 | .277 | 5.83 | 4.03 | 93 | 4.67 | 1.80 | 0.55 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2049 | 15 | 0 | 18 | 28.1 | 2 | 3 | 1 | 2 | 37 | 22 | 31 | 7 | 26.4% | 15.71% | 5.0% | 69.3% | 60.0% | 1.87 | .348 | 6.35 | 5.14 | 117 | 3.71 | 1.21 | -0.16 |
Total - AA
AA
|
0 | 11 | 27.1 | 0 | 1 | 0 | 0 | 8 | 8 | 26 | 4 | 7.2% | 7.21% | 3.6% | 68.0% | 52.9% | 1.24 | .244 | 4.94 | 5.72 | 137 | 5.46 | -0.78 | -0.38 | ||
Total - A
A
|
6 | 49 | 92.2 | 2 | 7 | 4 | 3 | 77 | 45 | 85 | 8 | 19.2% | 11.22% | 2.0% | 72.2% | 59.0% | 1.40 | .297 | 3.98 | 4.82 | 105 | 4.84 | -0.84 | 0.17 | ||
Total - S A
S A
|
43 | 76 | 282.0 | 5 | 28 | 1 | 1 | 218 | 129 | 360 | 50 | 16.3% | 9.62% | 3.7% | 64.1% | 56.7% | 1.73 | .341 | 6.80 | 5.92 | 140 | 4.99 | 0.88 | -2.15 | ||
Total - R
R
|
4 | 9 | 28.1 | 0 | 2 | 0 | 0 | 18 | 18 | 25 | 4 | 14.0% | 13.95% | 3.1% | 55.8% | 48.4% | 1.52 | .247 | 5.40 | 6.09 | 141 | 6.10 | -0.69 | -0.24 | ||
Total - HS
HS
|
15 | 33 | 87.1 | 3 | 5 | 1 | 2 | 109 | 68 | 75 | 11 | 26.7% | 16.67% | 2.7% | 70.1% | 63.6% | 1.64 | .305 | 4.74 | 4.28 | 95 | 4.38 | 0.46 | 1.33 | ||
Total - Minors
Minors
|
53 | 145 | 430.1 | 7 | 38 | 5 | 4 | 321 | 200 | 496 | 66 | 16.2% | 10.09% | 3.3% | 65.3% | 56.4% | 1.62 | .320 | 5.98 | 5.68 | 132 | 5.06 | 0.30 | -2.60 |